WuXi Healthcare Ventures II, L.P. - Net Worth and Insider Trading

WuXi Healthcare Ventures II, L.P. Net Worth

The estimated net worth of WuXi Healthcare Ventures II, L.P. is at least $320 Million dollars as of 2024-06-22. WuXi Healthcare Ventures II, L.P. is the 2101 Beneficial owner of CStone Pharmaceuticals and owns about 293,381,444 shares of CStone Pharmaceuticals (HKSE:02616) stock worth over $320 Million. Details can be seen in WuXi Healthcare Ventures II, L.P.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that WuXi Healthcare Ventures II, L.P. has not made any transactions after 2023-02-15 and currently still holds the listed stock(s).

Transaction Summary of WuXi Healthcare Ventures II, L.P.

To

WuXi Healthcare Ventures II, L.P. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, WuXi Healthcare Ventures II, L.P. owns 1 companies in total, including CStone Pharmaceuticals (HKSE:02616) .

Click here to see the complete history of WuXi Healthcare Ventures II, L.P.’s form 4 insider trades.

Insider Ownership Summary of WuXi Healthcare Ventures II, L.P.

Ticker Comapny Transaction Date Type of Owner
HKSE:02616 CStone Pharmaceuticals 2023-02-15 2101 Beneficial owner

WuXi Healthcare Ventures II, L.P. Latest Holdings Summary

WuXi Healthcare Ventures II, L.P. currently owns a total of 1 stock. WuXi Healthcare Ventures II, L.P. owns 293,381,444 shares of CStone Pharmaceuticals (HKSE:02616) as of February 15, 2023, with a value of $320 Million.

Latest Holdings of WuXi Healthcare Ventures II, L.P.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HKSE:02616 CStone Pharmaceuticals 2023-02-15 293,381,444 1.09 319,785,774

Holding Weightings of WuXi Healthcare Ventures II, L.P.


WuXi Healthcare Ventures II, L.P. Form 4 Trading Tracker

According to the SEC Form 4 filings, WuXi Healthcare Ventures II, L.P. has made a total of 2 transactions in CStone Pharmaceuticals (HKSE:02616) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in CStone Pharmaceuticals is the sale of 0 shares on February 15, 2023, which brought WuXi Healthcare Ventures II, L.P. around $0.

Insider Trading History of WuXi Healthcare Ventures II, L.P.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

WuXi Healthcare Ventures II, L.P. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

WuXi Healthcare Ventures II, L.P. Ownership Network

Ownership Network List of WuXi Healthcare Ventures II, L.P.

No Data

Ownership Network Relation of WuXi Healthcare Ventures II, L.P.

Insider Network Chart

WuXi Healthcare Ventures II, L.P. Owned Company Details

What does CStone Pharmaceuticals do?

Who are the key executives at CStone Pharmaceuticals?

WuXi Healthcare Ventures II, L.P. is the 2101 Beneficial owner of CStone Pharmaceuticals. Other key executives at CStone Pharmaceuticals include 2101 Beneficial owner Yang Jianxin , 2101 Beneficial owner Su Zhou Gong Ye Yuan Qu Zheng Ze Yuan Shi Chuang Ye Tou Zi Qi Ye You Xian He Huo , and 2201 Interest of corporation controlled by you Su Zhou Gong Ye Yuan Qu Zheng Ze Ji Ming Gu Quan Tou Zi Guan Li You Xian Gong Si .

CStone Pharmaceuticals (HKSE:02616) Insider Trades Summary

Over the past 18 months, WuXi Healthcare Ventures II, L.P. made no insider transaction in CStone Pharmaceuticals (HKSE:02616). Other recent insider transactions involving CStone Pharmaceuticals (HKSE:02616) include a net sale of 0 shares made by Morgan Stanley , a net sale of 17,667,742 shares made by Su Zhou Gong Ye Yuan Qu Zheng Ze Ji Ming Gu Quan Tou Zi Guan Li You Xian Gong Si , and a net sale of 17,667,742 shares made by Su Zhou Yuan He Kong Gu Gu Fen You Xian Gong Si .

In summary, during the past 3 months, insiders sold 0 shares of CStone Pharmaceuticals (HKSE:02616) in total and bought 350,000 shares, with a net purchase of 350,000 shares. During the past 18 months, 141,341,936 shares of CStone Pharmaceuticals (HKSE:02616) were sold and 350,000 shares were bought by its insiders, resulting in a net sale of 140,991,936 shares.

CStone Pharmaceuticals (HKSE:02616)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

CStone Pharmaceuticals Insider Transactions

No Available Data

WuXi Healthcare Ventures II, L.P. Mailing Address

Above is the net worth, insider trading, and ownership report for WuXi Healthcare Ventures II, L.P.. Currently GuruFocus does not have mailing address information for WuXi Healthcare Ventures II, L.P..

Discussions on WuXi Healthcare Ventures II, L.P.

No discussions yet.